Loveworld to host international symposium in Lagos

By Doris Obinna

The 2024 International Loveworld Medical Symposium on Radionuclide Therapy and Oncology is set to hold in Lagos, which is aimed at shaping future of nuclear medicine

The event, which would take place on Saturday, July 6, 2024, at the Loveworld Medical Centre, located at 51/53, Kudirat Abiola Way, Oregun, Lagos, has its theme centred on the “Evolving Role of Nuclear Medicine and Personalized & Precision Medicine.” It will gather some of the leading minds and practitioners in the field of nuclear medicine and oncology from around the globe.

Chief host is the executive chairman, Loveworld Medical Centre, Dr. Deola Phillips; host, chief operating officer, Loveworld Medical Centre, Dr. Anthony Oseghale; while clinical director, Loveworld Medical Centre, and chairman ISRT-Lagos 2024, Dr. Emeka Eze, is the symposium’s chairman.

Other distinguished speakers include: Nuclear Medicine Physician, Loveworld Medical Centre; Secretary, World Association of Radiopharmaceutical & Molecular Therapy (WARMTH), Dr. Masha Maharaj; Head of Department, Nuclear Medicine, Klinikum Frankfurt (Oder), Prof. Knut Liepe; Chief Specialist and Head of Nuclear Medicine, University of the Witwatersrand, Charlotte Maxeke Johannesburg Academic Hospital, Prof. Mboyo-Di-Tamba Willy Vangu; Head, Radionuclide Therapy Department, Research Institute of Clinical and Experimental Radiology, N.N. Blokhin NMRCO, Prof. Tamara Geliashvili; Professor, Nuclear Medicine Department, Almazov National Medical Centre, Prof. Andrey A. Stanjevskii; Chief Consultant Nuclear Medicine Physician, Radiation and Clinical Oncologist, National Hospital, Abuja, Nigeria, Dr. Foluso Arewa and Nuclear Regulatory Authority (NNRA) Coordinator, South West Zonal Office, Lagos, Nigeria, Mr. Adamu Abdul.

Loveworld Medical Centre in its statement disclosed that the symposium is meant to explore the latest advancements and innovations in nuclear medicine, particularly focusing on the growing impact of personalized and precision medicine in treating cancer and other health conditions.

Attendees will have the opportunity to engage with international experts, gain insights into groundbreaking research, and explore collaborative opportunities.

“Given the dynamic landscape of radionuclide therapy and oncology, this event marks a significant milestone for medical professionals, researchers, and policy makers dedicated to advancing healthcare outcomes through the power of nuclear medicine.

“Join us for an enriching experience that promises to set new standards in medical symposiums and fuel the progression of precision medicine,” said the organizers.